{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:16:23Z","timestamp":1791994583050,"version":"4.4.0"},"reference-count":92,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T00:00:00Z","timestamp":1562025600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.01506","type":"journal-article","created":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T00:53:46Z","timestamp":1562028826000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":142,"title":["New Insights Into the Pathogenesis of Bullous Pemphigoid: 2019 Update"],"prefix":"10.3389","volume":"10","author":[{"given":"Giovanni","family":"Genovese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Di Zenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Cozzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Berti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Cugno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo Valerio","family":"Marzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,7,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s12016-017-8633-4","article-title":"Autoimmune subepidermal bullous diseases of the skin and mucosae: clinical features, diagnosis, and management","volume":"54","author":"Amber","year":"2018","journal-title":"Clin Rev Allergy Immunol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.autrev.2015.01.006","article-title":"Atypical presentations of bullous pemphigoid: clinical and immunopathological aspects","volume":"14","author":"Cozzani","year":"2015","journal-title":"Autoimmun Rev."},{"key":"B3","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/exd.12146","article-title":"Bullous pemphigoid: role of complement and mechanisms for blister formation within the lamina lucida","volume":"22","author":"Iwata","year":"2013","journal-title":"Exp Dermatol."},{"key":"B4","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.4049\/jimmunol.136.4.1231","article-title":"Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting","volume":"136","author":"Labib","year":"1986","journal-title":"J Immunol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/1523-1747.ep12484863","article-title":"Partial cDNA cloning of the 230-kD mouse bullous pemphigoid antigen by use of a human monoclonal anti-basement membrane zone antibody","volume":"95","author":"Amagai","year":"1990","journal-title":"J Invest Dermatol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/1523-1747.ep12876200","article-title":"Production of rabbit antibodies against carboxy-terminal epitopes encoded by bullous pemphigoid cDNA","volume":"95","author":"Tanaka","year":"1990","journal-title":"J Invest Dermatol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1111\/1523-1747.ep12876194","article-title":"Two groups of bullous pemphigoid antigens are identified by affinity-purified antibodies","volume":"94","author":"Meyer","year":"1990","journal-title":"J Invest Dermatol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.3389\/fimmu.2017.01752","article-title":"BP180 is critical in the autoimmunity of bullous pemphigoid","volume":"8","author":"Liu","year":"2017","journal-title":"Front Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1111\/exd.13446","article-title":"Structural proteins of the dermal-epidermal junction targeted by autoantibodies in pemphigoid diseases","volume":"26","author":"Goletz","year":"2017","journal-title":"Exp Dermatol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/j.jid.2017.01.028","article-title":"Meeting report of the pathogenesis of pemphigus and pemphigoid meeting in Munich, September 2016","volume":"137","author":"Schmidt","year":"2017","journal-title":"J Invest Dermatol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1111\/exd.13415","article-title":"In vitro and in vivo models to investigate the pathomechanisms and novel treatments for pemphigoid diseases","volume":"26","author":"Bieber","year":"2017","journal-title":"Exp Dermatol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"8569","DOI":"10.1073\/pnas.93.16.8569","article-title":"A common major histocompatibility complex class II allele HLA-DQB1* 0301 is present in clinical variants of pemphigoid","volume":"93","author":"Delgado","year":"1996","journal-title":"Proc Natl Acad Sci USA."},{"key":"B13","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.clindermatol.2013.01.006","article-title":"Bullous pemphigoid: etiology, pathogenesis, and inducing factors: facts and controversies","volume":"31","author":"Lo Schiavo","year":"2013","journal-title":"Clin Dermatol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1111\/j.1600-0625.2011.01378.x","article-title":"Lesional Th17 cells and regulatory T cells in bullous pemphigoid","volume":"20","author":"Arakawa","year":"2011","journal-title":"Exp Dermatol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1016\/j.jaci.2018.08.028","article-title":"Regulatory T-cell deficiency and autoimmune skin disease: beyond the scurfy mouse and immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome","volume":"142","author":"Hashimoto","year":"2018","journal-title":"J Allergy Clin Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.coi.2009.08.005","article-title":"Activating systemic autoimmunity: B's, T's, and tolls","volume":"21","author":"Shlomchik","year":"2009","journal-title":"Curr Opin Immunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jaut.2018.09.003","article-title":"IL-17A is functionally relevant and a potential therapeutic target in bullous pemphigoid","volume":"96","author":"Chakievska","year":"2019","journal-title":"J Autoimmun."},{"key":"B18","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jdermsci.2015.01.013","article-title":"In vivo analysis of IgE autoantibodies in bullous pemphigoid: a study of 100 cases","volume":"78","author":"Moriuchi","year":"2015","journal-title":"J Dermatol Sci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1111\/j.1365-2133.2011.10481.x","article-title":"Detection of linear IgE deposits in bullous pemphigoid and mucous membrane pemphigoid: a useful clue for diagnosis","volume":"165","author":"Yayli","year":"2011","journal-title":"Br J Dermatol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jdermsci.2016.03.009","article-title":"High serum anti-BP180 IgE levels correlate to prominent urticarial lesions in patients with bullous pemphigoid","volume":"83","author":"Cho","year":"2016","journal-title":"J Dermatol Sci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/bjd.15114","article-title":"Detection of IgE autoantibodies to BP180 and BP230 and their relationship to clinical features in bullous pemphigoid","volume":"177","author":"Hashimoto","year":"2017","journal-title":"Br J Dermatol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1001\/jamadermatol.2016.3357","article-title":"Correlation of serum levels of ige autoantibodies against BP180 with bullous pemphigoid disease activity","volume":"153","author":"Van Beek","year":"2017","journal-title":"JAMA Dermatol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s00403-015-1598-3","article-title":"Levels of anti-BP180 NC16A IgE do not correlate with severity of disease in the early stages of bullous pemphigoid","volume":"307","author":"Bing","year":"2015","journal-title":"Arch Dermatol Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1111\/j.1582-4934.2007.00081.x","article-title":"IgG4 autoantibodies induce dermal-epidermal separation","volume":"11","author":"Mihai","year":"2007","journal-title":"J Cell Mol Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1038\/jid.2011.180","article-title":"Demonstration of epitope-spreading phenomena in bullous pemphigoid: results of a prospective multicenter study","volume":"131","author":"Di Zenzo","year":"2011","journal-title":"J Invest Dermatol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.jaad.2012.09.012","article-title":"Missing the target: characterization of bullous pemphigoid patients who are negative using the BP180 enzyme-linked immunosorbant assay","volume":"68","author":"Fairley","year":"2013","journal-title":"J Am Acad Dermatol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1001\/jamadermatol.2017.5465","article-title":"Clinical and immunological profiles of 14 patients with bullous pemphigoid without IgG autoantibodies to the BP180 NC16A domain","volume":"154","author":"Nakama","year":"2018","journal-title":"JAMA Dermatol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1016\/j.jid.2016.06.622","article-title":"Autoantibody profile differentiates between inflammatory and noninflammatory bullous pemphigoid","volume":"136","author":"Izumi","year":"2016","journal-title":"J Invest Dermatol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1111\/exd.13331","article-title":"Autoantibodies of non-inflammatory bullous pemphigoid hardly deplete type XVII collagen of keratinocytes","volume":"26","author":"Imafuku","year":"2017","journal-title":"Exp Dermatol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1111\/bjd.16553","article-title":"Prospective study in bullous pemphigoid: association of high serum anti-BP180 IgG levels with increased mortality and reduced Karnofsky score","volume":"179","author":"Holtsche","year":"2018","journal-title":"Br J Dermatol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.1172\/JCI116856","article-title":"A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180","volume":"92","author":"Liu","year":"1993","journal-title":"J Clin Invest."},{"key":"B32","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/nm1496","article-title":"Humanization of autoantigen","volume":"13","author":"Nishie","year":"2007","journal-title":"Nat Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1046\/j.1523-1747.1998.00126.x","article-title":"Detection of IgG autoantibodies in the sera of patients with bullous and gestational pemphigoid: ELISA studies utilizing a baculovirus-encoded form of bullous pemphigoid antigen 2","volume":"110","author":"Haase","year":"1998","journal-title":"J Invest Dermatol."},{"key":"B34","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1001\/archderm.136.2.174","article-title":"Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid","volume":"136","author":"Schmidt","year":"2000","journal-title":"Arch Dermatol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1038\/sj.jid.5700681","article-title":"IgE basement membrane zone antibodies induce eosinophil infiltration and histological blisters in engrafted human skin on SCID mice","volume":"127","author":"Zone","year":"2007","journal-title":"J Invest Dermatol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1038\/sj.jid.5700958","article-title":"A pathogenic role for IgE in autoimmunity: bullous pemphigoid IgE reproduces the early phase of lesion development in human skin grafted to nu\/nu mice","volume":"127","author":"Fairley","year":"2007","journal-title":"J Invest Dermatol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/jdv.15445","article-title":"Bullous pemphigoid: more than one disease?","volume":"33","author":"Ludwig","year":"2019","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2004.09.007","article-title":"Experimental bullous pemphigoid generated in mice with an antigenic epitope of the human hemidesmosomal protein BP230","volume":"24","author":"Kiss","year":"2005","journal-title":"J Autoimmun."},{"key":"B39","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.humimm.2014.01.005","article-title":"IgG antibodies against immunodominant C-terminal epitopes of BP230 do not induce skin blistering in mice","volume":"75","author":"Feldrihan","year":"2014","journal-title":"Hum Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1016\/j.jaci.2018.03.014","article-title":"Regulatory T-cell dysfunction induces autoantibodies to bullous pemphigoid antigens in mice and human subjects","volume":"142","author":"Muramatsu","year":"2018","journal-title":"J Allergy Clin Immunol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1016\/j.jaci.2018.04.006","article-title":"Regulatory T-cell deficiency leads to pathogenic bullous pemphigoid antigen 230 autoantibody and autoimmune bullous disease","volume":"142","author":"Haeberle","year":"2018","journal-title":"J Allergy Clin Immunol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1172\/JCI117826","article-title":"The role of complement in experimental bullous pemphigoid","volume":"95","author":"Liu","year":"1995","journal-title":"J Clin Invest."},{"key":"B43","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1038\/jid.2008.305","article-title":"IgG from patients with bullous pemphigoid depletes cultured keratinocytes of the 180-kDa bullous pemphigoid antigen (type XVII collagen) and weakens cell attachment","volume":"129","author":"Iwata","year":"2009","journal-title":"J Invest Dermatol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"4415","DOI":"10.4049\/jimmunol.1400095","article-title":"Bullous pemphigoid autoantibodies directly induce blister formation without complement activation","volume":"193","author":"Ujiie","year":"2014","journal-title":"J Immunol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/bjd.14411","article-title":"Bullous pemphigoid suggestive of complement-independent blister formation with anti-BP180 IgG4 autoantibodies","volume":"175","author":"Dainichi","year":"2016","journal-title":"Br J Dermatol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.ajpath.2012.11.029","article-title":"Bullous pemphigoid IgG induces BP180 internalization via a macropinocytic pathway","volume":"182","author":"Hiroyasu","year":"2013","journal-title":"Am J Pathol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"553","DOI":"10.4049\/jimmunol.1001753","article-title":"FcR-Independent Effects of IgE and IgG autoantibodies in bullous pemphigoid","volume":"187","author":"Messingham","year":"2011","journal-title":"J Immunol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"639","DOI":"10.3389\/fimmu.2018.00639","article-title":"Complement activation in inflammatory skin diseases","volume":"9","author":"Giang","year":"2018","journal-title":"Front Immunol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1111\/bjd.14822","article-title":"Complement in bullous pemphigoid: results from a large observational study","volume":"176","author":"Romeijn","year":"2017","journal-title":"Br J Dermatol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.3389\/fimmu.2018.02687","article-title":"Complement-activating capacity of autoantibodies correlates with disease activity in bullous pemphigoid patients","volume":"9","author":"Chiorean","year":"2018","journal-title":"Front Immunol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.jid.2017.08.030","article-title":"The anti-C1s antibody TNT003 prevents complement activation in the skin induced by bullous pemphigoid autoantibodies","volume":"138","author":"Kasprick","year":"2018","journal-title":"J Invest Dermatol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"488","DOI":"10.3389\/fimmu.2018.00488","article-title":"Tissue destruction in bullous pemphigoid can be complement independent and may be mitigated by C5aR2","volume":"9","author":"Karsten","year":"2018","journal-title":"Front Immunol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3389\/fimmu.2019.00200","article-title":"Bullous pemphigoid IgG induces cell dysfunction and enhances the motility of epidermal keratinocytes via Rac1\/proteasome activation","volume":"10","author":"Tie","year":"2019","journal-title":"Front Immunol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1016\/j.jid.2017.03.019","article-title":"TWEAK\/Fn14 activation contributes to the pathogenesis of bullous pemphigoid","volume":"137","author":"Liu","year":"2017","journal-title":"J Invest Dermatol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1111\/exd.13416","article-title":"Eosinophils as putative therapeutic targets in bullous pemphigoid","volume":"26","author":"Simon","year":"2017","journal-title":"Exp Dermatol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1111\/all.13131","article-title":"Evidence for a role of eosinophils in blister formation in bullous pemphigoid","volume":"72","author":"de Graauw","year":"2017","journal-title":"Allergy Eur J Allergy Clin Immunol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1111\/bjd.16679","article-title":"Peripheral eosinophilia in bullous pemphigoid: prevalence and influence on the clinical manifestation","volume":"179","author":"Kridin","year":"2018","journal-title":"Br J Dermatol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"689","DOI":"10.3389\/fimmu.2018.00689","article-title":"Immunoglobulin E-mediated autoimmunity","volume":"9","author":"Maurer","year":"2018","journal-title":"Front Immunol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"766","DOI":"10.2340\/00015555-2951","article-title":"Eosinophils are a major source of interleukin-31 in bullous pemphigoid","volume":"98","author":"R\u00fcdrich","year":"2018","journal-title":"Acta Derm Venereol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3389\/fmed.2018.00201","article-title":"The role of eosinophils in bullous pemphigoid: a developing model of eosinophil pathogenicity in mucocutaneous disease","volume":"5","author":"Amber","year":"2018","journal-title":"Front Med."},{"key":"B61","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/j.1365-2133.2008.08858.x","article-title":"IgE autoantibodies against the intracellular domain of BP180","volume":"160","author":"Dresow","year":"2009","journal-title":"Br J Dermatol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1684\/ejd.2018.3366","article-title":"Immunoglobulin E and bullous pemphigoid","volume":"28","author":"Cozzani","year":"2018","journal-title":"Eur J Dermatol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.jid.2017.11.031","article-title":"Eosinophils mediate tissue injury in the autoimmune skin disease bullous pemphigoid","volume":"138","author":"Lin","year":"2018","journal-title":"J Invest Dermatol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"e107725","DOI":"10.1371\/journal.pone.0107725","article-title":"Human eosinophils express the high affinity IgE receptor, FceRI, in bullous pemphigoid","volume":"9","author":"Messingham","year":"2014","journal-title":"PLoS ONE."},{"key":"B65","doi-asserted-by":"publisher","first-page":"407","DOI":"10.3389\/fimmu.2018.00407","article-title":"The autoimmune skin disease bullous pemphigoid: The role of mast cells in autoantibody-induced tissue injury","volume":"9","author":"Fang","year":"2018","journal-title":"Front Immunol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/j.1365-2133.2008.08880.x","article-title":"Activation of blood coagulation in bullous pemphigoid: Role of eosinophils, and local and systemic implications","volume":"160","author":"Marzano","year":"2009","journal-title":"Br J Dermatol."},{"key":"B67","first-page":"71","article-title":"Disturbances of the expression of metalloproteinases and their tissue inhibitors cause destruction of the basement membrane in pemphigoid","volume":"57","author":"Narbutt","year":"2006","journal-title":"Polish J Pathol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1111\/jdv.12464","article-title":"Eosinophil cationic protein levels parallel coagulation activation in the blister fluid of patients with bullous pemphigoid","volume":"29","author":"Tedeschi","year":"2015","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/870428","article-title":"Tissue factor in dermatitis herpetiformis and bullous pemphigoid: link between immune and coagulation system in subepidermal autoimmune bullous diseases","volume":"2015","author":"Zebrowska","year":"2015","journal-title":"Mediators Inflamm."},{"key":"B70","doi-asserted-by":"publisher","first-page":"e129456","DOI":"10.1371\/journal.pone.0129456","article-title":"Activation of blood coagulation in two prototypic autoimmune skin diseases: a possible link with thrombotic risk","volume":"10","author":"Cugno","year":"2015","journal-title":"PLoS ONE."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.3389\/fimmu.2017.01628","article-title":"Regulatory T cells suppress inflammation and blistering in pemphigoid diseases","volume":"8","author":"Bieber","year":"2017","journal-title":"Front Immunol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/s41598-018-19226-z","article-title":"Dysfunction of CD19+CD24hiCD27+ B regulatory cells in patients with bullous pemphigoid","volume":"8","author":"Liu","year":"2018","journal-title":"Sci Rep."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1111\/all.13376","article-title":"Monocytes enhance neutrophil-induced blister formation in an ex vivo model of bullous pemphigoid","volume":"73","author":"de Graauw","year":"2018","journal-title":"Allergy Eur J Allergy Clin Immunol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/path.5061","article-title":"Proinflammatory role of blister fluid-derived exosomes in bullous pemphigoid","volume":"245","author":"Fang","year":"2018","journal-title":"J Pathol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-28070-0","article-title":"Granzyme B is elevated in autoimmune blistering diseases and cleaves key anchoring proteins of the dermal-epidermal junction","volume":"8","author":"Russo","year":"2018","journal-title":"Sci Rep."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1111\/exd.13401","article-title":"Neurological and psychiatric associations in bullous pemphigoid\u2014more than skin deep?","volume":"26","author":"F\u00f6rsti","year":"2017","journal-title":"Exp Dermatol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"240570","DOI":"10.1155\/2013\/240570","article-title":"Collagen XVII: a shared antigen in neurodermatological interactions?","volume":"2013","author":"Sepp\u00e4nen","year":"2013","journal-title":"Clin Dev Immunol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s12026-018-9028-1","article-title":"Biological predictors shared by dementia and bullous pemphigoid patients point out a cross-antigenicity between BP180\/BP230 brain and skin isoforms","volume":"66","author":"Julio","year":"2018","journal-title":"Immunol Res."},{"key":"B79","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.jid.2018.09.010","article-title":"BP180 autoantibodies target different epitopes in multiple sclerosis or Alzheimer's disease than in bullous pemphigoid","volume":"139","author":"Tuusa","year":"2019","journal-title":"J Invest Dermatol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"779","DOI":"10.3389\/fimmu.2018.00779","article-title":"Humoral epitope spreading in autoimmune bullous diseases","volume":"9","author":"Didona","year":"2018","journal-title":"Front Immunol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1111\/j.1365-2133.2012.10982.x","article-title":"Evidence for vitamin D deficiency and increased prevalence of fractures in autoimmune bullous skin diseases","volume":"167","author":"Marzano","year":"2012","journal-title":"Br J Dermatol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13023-015-0230-0","article-title":"Vitamin D and skeletal health in autoimmune bullous skin diseases: a case control study","volume":"10","author":"Marzano","year":"2015","journal-title":"Orphanet J Rare Dis."},{"key":"B83","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.autrev.2011.05.002","article-title":"Effects of vitamin D on the peripheral adaptive immune system: a review","volume":"10","author":"Peelen","year":"2011","journal-title":"Autoimmun Rev."},{"key":"B84","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jdermsci.2007.12.003","article-title":"Vitamin D3 inhibits expression of bullous pemphigoid antigen 1 through post-transcriptional mechanism without new protein synthesis","volume":"50","author":"Yamamoto","year":"2008","journal-title":"J Dermatol Sci."},{"key":"B85","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/jdv.12929","article-title":"Calcitriol exerts anti-inflammatory effects in keratinocytes treated with autoantibodies from a patient with bullous pemphigoid","volume":"30","author":"Tukaj","year":"2016","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.jid.2017.09.009","article-title":"Calcitriol treatment ameliorates inflammation and blistering in mouse models of epidermolysis bullosa acquisita","volume":"138","author":"Tukaj","year":"2018","journal-title":"J Invest Dermatol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1111\/j.1365-2133.2009.09350.x","article-title":"A population-based study of acute medical conditions associated with bullous pemphigoid","volume":"161","author":"Langan","year":"2009","journal-title":"Br J Dermatol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/sj.bjc.6602945","article-title":"Increased risk of venous thromboembolism in patients with bullous pemphigoid. The INVENTEP (INcidence of VENous ThromboEmbolism in bullous Pemphigoid) study","volume":"115","author":"Cugno","year":"2016","journal-title":"Thromb Haemost."},{"key":"B89","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/j.1365-2249.2009.03989.x","article-title":"Coagulation activation in autoimmune bullous diseases","volume":"158","author":"Marzano","year":"2009","journal-title":"Clin Exp Immunol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/j.1365-2249.2011.04391.x","article-title":"Activation of coagulation in bullous pemphigoid and other eosinophil-related inflammatory skin diseases","volume":"165","author":"Marzano","year":"2011","journal-title":"Clin Exp Immunol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1365-2249.2012.04674.x","article-title":"Prothrombotic state and impaired fibrinolysis in bullous pemphigoid, the most frequent autoimmune blistering disease","volume":"171","author":"Marzano","year":"2013","journal-title":"Clin Exp Immunol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1111\/exd.13382","article-title":"Analysis of serum markers of cellular immune activation in patients with bullous pemphigoid","volume":"26","author":"Bieber","year":"2017","journal-title":"Exp Dermatol."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01506\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T18:24:00Z","timestamp":1694975040000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01506\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,2]]},"references-count":92,"alternative-id":["10.3389\/fimmu.2019.01506"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.01506","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,2]]},"article-number":"1506"}}